Biotech stocks down at noon

By Staff Writers
Wednesday, 11 March, 2009

At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.

Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.

Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.

Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.

Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.

Related News

'Mini brains' mimic MS myelin damage

The MS organoids give researchers a highly detailed cellular view of myelin destruction...

Fast-aging placentas may contribute to pre-eclampsia

Placentas affected by pre-eclampsia show several signs of accelerated aging, including increased...

BioNTech opens mRNA manufacturing facility at La Trobe

Offering state-subsidised access to researchers and biotech startups, the facility aims to enable...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd